Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7573971

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
Key financial data of group
Business results of group
Net sales
80,707,000,000 JPY
105,534,000,000 JPY
77,717,000,000 JPY
Ordinary profit (loss)
5,336,000,000 JPY
5,569,000,000 JPY
3,515,000,000 JPY
Profit (loss) attributable to owners of parent
4,377,000,000 JPY
3,932,000,000 JPY
2,483,000,000 JPY
Comprehensive income
5,300,000,000 JPY
3,625,000,000 JPY
1,971,000,000 JPY
Net assets
126,788,000,000 JPY
124,507,000,000 JPY
122,853,000,000 JPY
Total assets
174,562,000,000 JPY
171,924,000,000 JPY
169,106,000,000 JPY
Basic earnings (loss) per share
76.40
54.71
68.62
43.34
41.21
Diluted earnings per share
Equity-to-asset ratio
0.726 xbrli:pure
0.724 xbrli:pure
0.726 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.